Self instill twist housing eye drop dispenser
Latest Allergan Sales, Inc. Patents:
- GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
- Leucine-based motifs and enhanced biological persistence of clostridial neurotoxins
- Calcium blockers to treat proliferative vitreoretinopathy
- GFP-SNAP25 fluorescence release assay for botulinum neurotoxin protease activity
- Pain treatment by peripheral administration of a neurotoxin
Description
FIG. 1 is a top, front and left side perspective view of a self instill twist housing eye drop dispenser showing our new design;
FIG. 2 is a front elevation view;
FIG. 3 is a left side elevation view and the right side is an exact mirror image of the left side;
FIG. 4 is a back elevation view;
FIG. 5 is a top plan view; and,
FIG. 6 is a bottom plan view.
The broken line showing in FIGS. 1 through 4 is for illustrative purposes only and forms no part of the claimed design.
Claims
The ornamental design for a self instill twist housing eye drop dispenser, as shown and described.
Referenced Cited
Patent History
Patent number: D444874
Type: Grant
Filed: Jul 31, 2000
Date of Patent: Jul 10, 2001
Assignee: Allergan Sales, Inc. (Irvine, CA)
Inventors: David S. Haffner (Mission Viejo, CA), Terence Arjo (San Francisco, CA), Patrick A. Myall (San Francisco, CA)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Walter A. Hackler
Application Number: 29/127,142
Type: Grant
Filed: Jul 31, 2000
Date of Patent: Jul 10, 2001
Assignee: Allergan Sales, Inc. (Irvine, CA)
Inventors: David S. Haffner (Mission Viejo, CA), Terence Arjo (San Francisco, CA), Patrick A. Myall (San Francisco, CA)
Primary Examiner: Ian Simmons
Attorney, Agent or Law Firm: Walter A. Hackler
Application Number: 29/127,142
Classifications
Current U.S. Class:
Eye Cup (D24/120);
D9/569;
Receptacle Or Vessel (14) (D24/121)
International Classification: 2402;
International Classification: 2402;